What Side Effects Can I Expect with Dara-CyBorD Treatment?

Starting the Dara-CyBorD regimen—which combines daratumumab, cyclophosphamide, bortezomib, and dexamethasone—can feel daunting. This combination is a common first-line regimen for many newly diagnosed patients with AL amyloidosis, but the dose and schedule are highly individualized based on your heart function, kidney health, and overall frailty ^[1][2]. The most common issues include fatigue, an increased risk of infections, nerve changes from bortezomib, sleep and mood fluctuations from dexamethasone, and temporary reactions when receiving daratumumab ^[3][4]. Importantly, some of these symptoms (like fatigue or swelling) can also be caused by the amyloidosis itself ^[5].

When to Call Your Care Team Urgently

Do not wait for your next appointment if you experience serious warning signs. Call your oncology clinic immediately—or seek emergency care—if you develop:

• Fever or chills: A temperature of 100.4°F (38.0°C) or higher, or shaking chills (ask your clinic for their specific fever threshold).
• Breathing or heart issues: New or worsening shortness of breath, chest pain, or wheezing.
• Severe allergic symptoms: Facial or throat swelling, severe dizziness, or fainting, which can happen hours after leaving the clinic.
• Fluid and kidney changes: Rapid weight gain, rapidly worsening swelling in your legs or belly, or a sudden drop in how much you urinate.
• Neurological or mood changes: Severe confusion, extreme mood changes (including mania, deep depression, or suicidal thoughts), or sudden muscle weakness.
• Bleeding or urinary issues: Unusual bruising, bleeding, or blood/burning when you urinate.

How Each Medication Affects Your Body

Because Dara-CyBorD is a combination of four distinct drugs, the side effects usually trace back to specific components of the regimen.

Bortezomib (Velcade) and Nerve Symptoms
Bortezomib frequently causes peripheral neuropathy, a type of nerve damage ^[6]. You might feel numbness, a “pins and needles” tingling, or a burning pain that usually starts in the toes and fingers (often called a “stocking-and-glove” pattern) ^[4]. It can also cause autonomic symptoms like dizziness when standing up, or constipation ^[4]. The risk increases with higher doses or if you already have nerve issues or diabetes ^[6]. Receiving bortezomib as a weekly injection under the skin (subcutaneously) rather than through an IV lowers this risk ^[7]. It is critical to tell your doctor at the very first sign of tingling or weakness; early reporting reduces the risk of worsening and allows the team to decide if the dose needs to be lowered or held ^[4][8].

Dexamethasone and the “Steroid Rollercoaster”
Dexamethasone is a powerful corticosteroid. Many patients experience a surge of energy, difficulty sleeping (insomnia), irritability, or mood swings on the days they take it, sometimes followed by fatigue a few days later ^[9]. Dexamethasone can also increase your appetite and blood sugar. Because AL amyloidosis often affects the heart and kidneys, steroids can cause dangerous fluid retention; carefully monitoring your weight for sudden fluid buildup is essential ^[5][10]. Never adjust your dose of steroids, diuretics (water pills), or fluid/salt intake on your own—always consult your team first ^[2].

Daratumumab (Darzalex) and Administration Reactions
Daratumumab can cause reactions during or after you receive it. Symptoms might resemble an allergy or cold, including a runny nose, chills, cough, or shortness of breath ^[11]. These reactions occur most often with the first dose, but they can occasionally happen with later doses or hours after you leave the clinic ^[12][13]. Today, daratumumab is typically given as a quick injection under the skin, which reduced the reaction rate to about 7% in the pivotal ANDROMEDA trial ^[3][14]. You will receive pre-medications like antihistamines and acetaminophen to help prevent these reactions ^[15].
Important Note on Blood Typing: Daratumumab interferes with the antibody tests blood banks use to match blood types ^[3]. Inform all healthcare providers and blood banks that you are on this medication in case you ever need a blood transfusion.

Cyclophosphamide and General Chemotherapy Effects
Cyclophosphamide contributes to fatigue and lowers your blood counts, including your infection-fighting white blood cells and your blood-clotting platelets (increasing bleeding risk) ^[3]. It can also cause nausea, changes to your hair, and irritation to the bladder ^[3]. Drink fluids as directed by your team and report any blood in your urine immediately. Because cyclophosphamide can impact fertility and fetal development, discuss contraception or fertility preservation with your doctor before starting treatment.

System-Wide Risks to Watch

Beyond the day-to-day symptoms, the regimen impacts your immune system and organs.

• Infections: The regimen significantly lowers your white blood cells, including both lymphopenia (low lymphocytes) and neutropenia (low neutrophils). In the ANDROMEDA trial, pneumonia was a common severe side effect, occurring in nearly 8% of patients ^[3]. Your doctor may recommend preventive antiviral medications (like those for shingles) or antibacterial/Pneumocystis medications based on your specific blood counts and risk factors ^[16].
• Fluid and Organ Stress: Diarrhea and fluid shifts can be particularly dangerous if amyloid proteins have already damaged your heart or kidneys ^[3][5]. Your team will closely monitor your kidney function and heart health to safely manage your body’s fluid balance ^[2].